Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes

By Miyazawa M.   Gyoubu K.  

Xenobiotica, Vol. 37, Iss. 2, 2007-02 ,pp. : 194-204

Informa Healthcare

Access to resources Recommend Favorite

CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes

By Hu Y.   Dehal S. S.   Hynd G.   Jones G. B.   Kupfer D.  

Xenobiotica, Vol. 33, Iss. 2, 2003-02 ,pp. : 141-151

Informa Healthcare

Access to resources Recommend Favorite

Involvement of CYP2D1 in the metabolism of carteolol by male rat liver microsomes

By Umehara K.   Kudo S.   Odomi M.  

Xenobiotica, Vol. 27, Iss. 11, 1997-11 ,pp. : 1121-1129

Informa Healthcare

Access to resources Recommend Favorite

Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4

By Lewis D. F. V.   Lake B. G.   P. M. Dickins   Eddershaw J.   Tarbit M. H.   Goldfarb P. S.  

Xenobiotica, Vol. 29, Iss. 4, 1999-04 ,pp. : 361-393

Informa Healthcare

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite